Antibacterial Metabolites from Australian Macrofungi from the Genus Cortinarius
There are no files associated with this record.
| Title | Antibacterial Metabolites from Australian Macrofungi from the Genus Cortinarius |
|---|---|
| Author | Beattie, Karren; Rouf, Razina; Gander, Louisa Jane; May, T.; Ratkowsky, D.; Donner, C.; Grice, Darren; Tiralongo, Evelin |
| Publication Title | Planta Medica, vol 76 (12) |
| Year Published | 2010 |
| Place of publication | Germany |
| Publisher | Thieme |
| Abstract | Mushrooms have demonstrated significant pharmacological activity including antimicrobial, cytotoxic, anti-inflammatory, hypoglycaemic, immunomodulatory and hallucinogenic properties [1]. The fungi of Australia are diverse, largely endemic and, in contrast to their floral counterparts, have not undergone intensive taxonomic, chemical or pharmacological evaluation [2]. Furthermore, some Australian indigenous macrofungi are currently considered to be conspecific with Northern Hemisphere species, might be described as separate species once taxonomic revisions are carried out [3]. Consequently Australian mushrooms represent an under-explored resource of potentially novel metabolites. In this study, ethyl acetate and aqueous fractions from 117 collections of Australian macrofungi belonging to the genusCortinarius were screened for antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa. Overall, the lipophilic fractions were more active than the aqueous fractions. The ethyl acetate fractions of most or all collections of 13 described Cortinarius species and 47 collections of un-described Cortinarius species exhibited IC50 values of ≤0.09mg/mL against S. aureus. In contrast, most or all collections of only 4 described Cortinarius species and only 11 un-described Cortinarius collections exhibited similar effects against P. aeruginosa (IC50 ≤0.09mg/mL). The fungal octaketides austrocortilutein, austrocortirubin, torosachrysone, isolated from C. basirubescens, together with physcion and emodin were found to strongly inhibit the growth of S. aureus (IC50 0.7-12µg/mL) whereas only physcion and emodin exhibited potency against P. aeruginosa (IC50 1.5 and 2.0µg/mL, respectively) [4]. Australian mushrooms from the genus Cortinarius are promising sources of natural products for further drug development research, due to the high biological diversity and unique evolutionary lineages found only in the region. This is coupled with the large proportion of bioactive species and high diversity of chemical constituents. |
| Peer Reviewed | No |
| Published | Yes |
| Alternative URI | http://dx.doi.org/10.1055/s-0030-1264725 |
| ISBN | 0032-0943 |
| Conference name | 58th Int. Congress & Annual Meeting of the Society for Medicinal Plant and Natural Product Research |
| Location | Berlin |
| Date From | 2010-08-29 |
| Date To | 2010-09-02 |
| URI | http://hdl.handle.net/10072/37231 |
| Date Accessioned | 2011-01-31 |
| Date Available | 2011-03-15T08:02:41Z |
| Language | en_AU |
| Research Centre | Griffith Health Institute; Eskitis Institute for Drug Discovery; Institute for Glycomics; Molecular Basis of Disease |
| Faculty | Griffith Health Faculty |
| Subject | PRE2009-Complementary/Alternative Medicine |
| Publication Type | Conference Publications (Extract Paper) |
| Publication Type Code | e3 |
Please use this identifier to cite this record: http://hdl.handle.net/10072/37231
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top